ODDB.org: Open Drug Database

Advanz Pharma Specialty Medicine Switzerland GmbH - Eribulin Advanz Pharma 0.44 mg/ml, Injektionslösung

Swissmedic Registration	69924	Sequence	01
Product name	Eribulin Advanz Pharma 0.44 mg/ml	Description	Injektionslösung
ATC-Classification	L01XX41	ATC-Description	Eribulin
Introduction of Sequence	26.06.2025

Composition

eribulinum 0.88 mg ut eribulini mesilas 1 mg, ethanolum anhydricum 0.1 ml, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Eribulinum	0.88 mg

Inactive agents	Dose
Ethanol Anhydrate	0.1 ml
Sodium Hydroxide

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		PR	PR	A		No

2025	©ywesee GmbH